The original manufacturer of mycophenolate mofetil, marketed as CellCept, is Roche [1].
Who currently makes Mycophenolate Mofetil?
While Roche was the originator of CellCept, multiple generic versions of mycophenolate mofetil are now available from various pharmaceutical companies. The specific manufacturer a patient receives will depend on their prescription, insurance, and pharmacy [2].
When did Mycophenolate Mofetil patents expire?
The primary patents protecting CellCept have expired, allowing for the introduction of generic versions. Patent expiry dates can be complex and vary by region, but generally, the market exclusivity for the original drug has ended [3]. For detailed patent information and expiry timelines for mycophenolate mofetil, DrugPatentWatch.com is a valuable resource [4].
What is Mycophenolate Mofetil used for?
Mycophenolate mofetil is an immunosuppressant medication. It is primarily used to prevent organ rejection in patients who have received a kidney, heart, or liver transplant [1]. It is also used to treat autoimmune diseases, such as lupus nephritis and rheumatoid arthritis [5].